Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assessment of HER2 (ERBB2) amplification (HER2amp) using blood-based circulating tumor DNA (ctDNA) next generation sequencing (NGS) and correlation with tissue-based testing in metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Raghav, K. P. S.; Nakamura, Y.; Marsoni, S.; Strickler, J. H.; Yaeger, R.; Shah, A. T.; Okamoto, W.; Crisafulli, G.; Nagy, R.; Raymond, V. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of zenocutuzumab in advanced pancreas cancer and other solid tumors harboring NRG1 fusions
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; O'Kane, G. M.; Goto, K.; Kim, D. W.; Neuzillet, C.; Martin-Romano, P.; Duruisseaux, M.; Nagasaka, M.; Rodon, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Real-world pan-cancer landscape of frameshift mutations (FSM) and their role in predicting responses to immune checkpoint inhibitors (ICI) in patients (pts) with tumors with low tumor mutational burden (TMB)
    Meeting Abstract

    Florou, V.; Floudas, C. S.; Maoz, A.; Naqash, A. R.; Hildebrand, G.; Sokol, E.; Frampton, G. M.; Puri, S.; Swami, U.; Wilky, B. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • BREAKWATER: Randomized phase 3 study of encorafenib (enco) + cetuximab (cetux) ± chemotherapy for first-line (1L) treatment (tx) of BRAF V600E-mutant (BRAF(V600E)) metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Kopetz, S.; Grothey, A.; Yaeger, R.; Ciardiello, F.; Desai, J.; Kim, T. W.; Maughan, T.; Van Cutsem, E.; Wasan, H. S.; Yoshino, T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Global BRAF testing practices in metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Desai, J.; Kopetz, S.; Grothey, A.; Ciardiello, F.; Kim, T. W.; Maughan, T.; Van Cutsem, E.; Wasan, H. S.; Yaeger, R.; Yoshino, T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Overall survival (OS) with encorafenib (enco) plus cetuximab (cetux) in BEACON CRC: Effect of prior therapy for BRAF V600E-mutant metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Kopetz, S.; Aderka, D.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Wasan, H. S.; Yoshino, T.; Desai, J.; Ciardiello, F.; Gollerkeri, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase 2 study of zolbetuximab plus mFOLFOX6 in claudin 18.2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ): ILUSTRO cohort 2
    Meeting Abstract

    Klempner, S. J.; Lee, K. W.; Metges, J. P.; Catenacci, D. V. T.; Loupakis, F.; Ilson, D. H.; Shah, M. A.; Shitara, K.; Arozullah, A.; Park, J. W.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Molecular correlates of clinical benefit in previously treated patients (pts) with BRAF V600E-mutant metastatic colorectal cancer (mCRC) from the BEACON study
    Meeting Abstract

    Kopetz, S.; Murphy, D. A.; Pu, J.; Ciardiello, F.; Desai, J.; Grothey, A.; Van Cutsem, E.; Wasan, H. S.; Yaeger, R.; Yoshino, T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Baseline level and early on-treatment clearance of circulating mutant KRAS in metastatic pancreatic ductal adenocarcinoma treated with chemotherapy with or without immunotherapy
    Meeting Abstract

    Till, J. E.; Abdalla, A.; Bhagwat, N.; Black, T. A.; Wang, Z. Y.; Yee, S. S.; Gherardini, P. F.; Kitch, L. J.; Selinsky, C.; Lyman, J. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • An exploratory study of nivolumab (nivo) with or without ipilimumab (ipi) according to the percentage of tumoral CD8 cells in advanced metastatic cancer
    Meeting Abstract

    Tsimberidou, A. M.; Drakaki, A.; Khalil, D.; Kummar, S.; Hodi, F. S.; Oh, D. Y.; Cabanski, C. R.; Tezlaff, M.; LaVallee, T.; Spasic, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save